// App-Quantinova.ai

P959 : CILTACABTAGENE AUTOLEUCEL IN LENALIDOMIDE-REFRACTORY PATIENTS WITH PROGRESSIVE MULTIPLE MYELOMA AFTER 1-3 PRIOR LINES OF THERAPY: CARTITUDE-2 BIOLOGICAL CORRELATIVE ANALYSES AND UPDATED CLINICAL DATA

Researchers

Presenter

  • Jens Hillengass

Principal Investigators

  • Michel Delforge

  • Hermann Einsele

  • Hartmut Goldschmidt

  • Katja Weisel

  • Marc-Steffen Raab

  • Christof Scheid

  • Jordan M. Schecter

  • Kevin C. De Braganca

  • Helen Varsos

  • Tzu-min Yeh

  • Pankaj Mistry

  • Tito Roccia

  • Christina Corsale

  • Muhammad Akram

  • Lida Pacaud

  • Tonia Nesheiwat

  • Mounzer Agha

  • Yael C. Cohen

Medical Centers

  • Medicine,UPMC Hillman Cancer Center,Pittsburgh,Vereinigte Staaten

  • Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • D,High Wycombe,Reino Unido

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • Legend Biotech USA Inc,Piscataway, NJ,Verenigde Staten

  • University Hospital Heidelberg, and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Res

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • D,Raritan,États-unis

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Roswell Park Comprehensive Cancer Center,Buffalo,Verenigde Staten

  • D,Raritan, NJ,Vereinigte Staaten

  • D,Raritan,United States

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • University Hospital Heidelberg, and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Res

  • University of Cologne, Cologne, DE, Germany

  • D,High Wycombe,Соединённое Королевство

  • University Medical Center Utrecht,

  • Medicine,Roswell Park Comprehensive Cancer Center,Buffalo,United States

  • University of Cologne,Cologne,Tyskland

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT),Heidelberg,Germania

  • University of Cologne, Cologne, DE, Germany

  • University Hospital Heidelberg, Internal Medi

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Tel-Aviv Sourasky (Ichilov) Medical Center and Sackler School of M

  • Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II,Würzburg,Deutschland

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA

  • University of Cologne,Cologne,Allemagne

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University Hospitals (UZ) Leuven,Leuven,Bélgica

  • D,High Wycombe,United Kingdom

  • D,High Wycombe,Royaume-uni

  • University of Cologne,Cologne,Tyskland

  • Legend Biotech USA,Piscataway, NJ,United States

  • UPMC Hillman Cancer Center,Pittsburg,Stati Uniti

  • University of Cologne,Cologne,Tyskland

  • Jansse

  • Legend Biotech USA,Piscataway,États-unis

  • University Hospital Heidelberg, and Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Res

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Legend Biotech USA Inc,Piscataway, NJ,Verenigde Staten

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • D, Raritan,NJ,Estados Unidos

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • University Clinic Cologne,Cologne,Deutschland

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • D,Raritan, NJ,Stati Uniti

  • D,High Wycombe,Verenigd Koninkrijk

  • D,Raritan,Verenigde S

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT),Heidelberg,Germania

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Janssen R&amp

  • Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • UPMC Hillman Cancer Center,Pittsburg,Stati Uniti

  • Legend Biotech USA, Piscataway,NJ,Estados Unidos

  • University Hospital of Cologne,Cologne,Германия

  • Abramson Cancer Center and University of Pennsylvania,Philadelphia, PA,États-unis

  • Legend Biotech USA,Piscataway,Stati Uniti

  • UPMC Hillman Cancer Center, Pittsburgh, PA, USA

  • Medicine,UPMC Hillman Cancer Center,Pittsburgh,Vereinigte Staaten

  • Tel Aviv Sourasky Medical Center and Sakler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  • UPMC Hillman Cancer Center,Pittsburgh,Verenigde Staten

  • University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT),Heidelberg,Germania

  • D,High Wycombe,Vereinigtes Königreich

  • D,High Wycombe,Reino Unido

  • University of Cologne,Cologne,Tyskland

  • D, Rarita

  • Legend Biot

  • UPM

  • University Hospital...

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • Universitätsklinikum Würzburg, Medizinische Klini

Locations

  • United States

  • Belgium

  • Germany

  • South Africa

  • United Kingdom

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • Cytokine release syndrome

  • Multiple Myeloma

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Interleukin 6

  • Twist-related protein 1

Drug/Treatment

  • Lenalidomide

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • II

Study Id's

  • NCT04133636

  • NCT04181827

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved